top of page
Perspectives on the Management of Metastatic Castration-Resistant Prostate Cancer
Medscape
7/1/22, 7:15 PM
Europe/Paris GMT+2
Description
FRIDAY, 1 JULY 2022
16:15 - 17:15
Welcome and Introductions
- Alison Birtle, MD, FRCP, FRCR
Current Unmet Needs in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Alison Birtle, MD, FRCP, FRCR
Can Novel Imaging Modalities Improve Disease Management in mCRPC
- Ken Herrmann, MD, MBA
Rationale and Clinical Evidence for Novel Therapies in mCRPC
- Niven Mehra, MD, PhD
Interactive Case Review and Audience Q&A
Closing Remarks
- Alison Birtle, MD, FRCP, FRCR
Previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
Alison Birtle
Welcome and Introductions, Current Unmet Needs in Metastatic Castration-Resistant Prostate Cancer (mCRPC), Can Novel Imaging Modalities Improve Disease Management in mCRPC, Rationale and Clinical Evidence for Novel Therapies in mCRPC, Interactive Case Review and Audience Q&A, Closing Remarks
Inglês
Description
Speakers
Ken Herrmann, Niven Mehra
Speakers
Link to Event
Banner
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.
Registro
bottom of page